LANXESS expands test capacity for high-performance additives
- Challenging test procedure for hydraulic fluids
- Approval for Additin RC 9200 N already granted
LANXESSAs the market requires test runs to be performed using various grades of oil and the test capacity at hydraulic unit manufacturer Bosch Rexroth is only available on a limited basis, the LANXESS Additives (ADD) business unit decided to build its own test bench to conduct these tests. Additin RC 9200 N had already been approved by the mechanical engineering company in March 2018. All end products that pass the test are published in a list of recommended products for high operational safety.
Successfully tested additive packages receive a seal of approval. This means that lubricant manufacturers that use one of these packages to formulate their hydraulic fluids meet the requirements of the hydraulic unit manufacturer and are listed accordingly – an incentive to buy Additin RC 9200 N. Another advantage of Additin RC 9200 N is that it is particularly economical to use as it is dosed at just 0.6 percent in the mineral base oil. Similar products have a significantly higher dose of additive ranging from 0.85 to 0.95 percent.
Challenging test procedure for hydraulic fluids
The operational safety of its hydraulic pumps and motors is extremely important to Bosch Rexroth. Until now, the company had carried out the relevant tests for Additin RC 9200 N itself in accordance with its internal guideline RDE 90235 (“Hydraulic fluids based on mineral oils and related hydrocarbons”). This is a scientifically standardized test procedure that assesses the behavior of the lubricant and the interaction in the hydraulic pump and motor under realistic operating conditions.
Bosch Rexroth is thus responding to the significantly increased power density of its systems and the equally more stringent requirements placed on the lubricant. The pump test introduced by Bosch Rexroth in 2015 goes far beyond what current DIN and ISO standards require.
Forward-Looking Statements
This company release contains certain forward-looking statements, including assumptions, opinions, expectations and views of the company or cited from third party sources. Various known and unknown risks, uncertainties and other factors could cause the actual results, financial position, development or performance of LANXESS AG to differ materially from the estimations expressed or implied herein. LANXESS AG does not guarantee that the assumptions underlying such forward-looking statements are free from errors, nor does it accept any responsibility for the future accuracy of the opinions expressed in this presentation or the actual occurrence of the forecast developments. No representation or warranty (expressed or implied) is made as to, and no reliance should be placed on, any information, estimates, targets and opinions contained herein, and no liability whatsoever is accepted as to any errors, omissions or misstatements contained herein, and accordingly, no representative of LANXESS AG or any of its affiliated companies or any of such person's officers, directors or employees accepts any liability whatsoever arising directly or indirectly from the use of this document.
